scispace - formally typeset
K

Kari Hemminki

Researcher at Charles University in Prague

Publications -  1324
Citations -  60117

Kari Hemminki is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 100, co-authored 1274 publications receiving 55290 citations. Previous affiliations of Kari Hemminki include Lund University & Novum.

Papers
More filters
Journal ArticleDOI

TERT Promoter Mutations in Familial and Sporadic Melanoma

TL;DR: A melanoma-prone family through linkage analysis and high-throughput sequencing was investigated and a disease-segregating germline mutation in the promoter of the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic subunit of telomersase, caused up to twofold increase in transcription.
Journal ArticleDOI

IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans

TL;DR: The most commonly studied genotoxicity endpoints have been selected for inclusion in this document and they are structural and numerical chromosomal aberrations assessed using cytogenetic methods (classical chromosomal aberration analysis (CA), fluorescence in situ hybridisation (FISH), micronuclei (MN), DNA damage (adducts, strand breaks, crosslinking, alkali-labile sites) assessed using bio-chemical/electrophoretic assays or sister chromatid exchanges (SCE); protein adducts; and hypoxanthine-
Journal ArticleDOI

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.

Thorunn Rafnar, +89 more
- 01 Feb 2009 - 
TL;DR: It is found that rs401681[C] on chromosome 5p15 satisfied the threshold for genome-wide significance and seems to confer protection against cutaneous melanoma, and investigation of the region led to rs2736098[A], which showed stronger association with some cancer types, but neither variant could fully account for the association of the other.